Rebecca A. English

• Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products
• Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant Tuberculosis
• Envisioning a Transformed Clinical Trials Enterprise in the United States : Establishing an Agenda for 2020
• Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the Brics
• Public engagement and clinical trials
• Transforming clinical research in the United States
• Building a National Framework for the Establishment of Regulatory Science for Drug Development
• Facing the Reality of Drug-Resistant Tuberculosis in India
• Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS : Challenges and Opportunities
• Large Simple Trials and Knowledge Generation in a Learning Health System
• Living with ALS
• Public Engagement and Clinical Trials : New Models and Disruptive Technologies